These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 9000700

  • 1. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.
    Kallmann BA, Hüther M, Tubes M, Feldkamp J, Bertrams J, Gries FA, Lampeter EF, Kolb H.
    Diabetes; 1997 Feb; 46(2):237-43. PubMed ID: 9000700
    [Abstract] [Full Text] [Related]

  • 2. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
    Pietropaolo M, Peakman M, Pietropaolo SL, Zanone MM, Foley TP, Becker DJ, Trucco M.
    J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
    [Abstract] [Full Text] [Related]

  • 3. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA, Rabin DU, Rowley MJ.
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [Abstract] [Full Text] [Related]

  • 4. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S, Penna G, Gregori S, Magistrelli G, Isacchi A, Adorini L.
    J Immunol; 2000 Dec 15; 165(12):6748-55. PubMed ID: 11120794
    [Abstract] [Full Text] [Related]

  • 5. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC, Stone N, de Aizpurua H, Rowley MJ, Harrison LC.
    J Autoimmun; 1997 Apr 15; 10(2):165-73. PubMed ID: 9185878
    [Abstract] [Full Text] [Related]

  • 6. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I, Hummel M, Ziegler AG.
    Diabetes; 1996 Jun 15; 45(6):795-800. PubMed ID: 8635655
    [Abstract] [Full Text] [Related]

  • 7. Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease.
    Aso Y, Matsuura H, Momobayashi A, Inukai Y, Sugawara N, Nakano T, Yamamoto R, Wakabayashi S, Takebayashi K, Inukai T.
    Endocr J; 2006 Jun 15; 53(3):377-85. PubMed ID: 16717396
    [Abstract] [Full Text] [Related]

  • 8. Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients.
    Ng WY, Thai AC, Lui KF, Yeo PP, Cheah JS.
    Diabetes Res Clin Pract; 1999 Feb 15; 43(2):127-35. PubMed ID: 10221665
    [Abstract] [Full Text] [Related]

  • 9. The relationship between humoral and cellular immunity to IA-2 in IDDM.
    Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, She JX, Notkins AL, Maclaren NK, Atkinson MA.
    Diabetes; 1998 Apr 15; 47(4):566-9. PubMed ID: 9568688
    [Abstract] [Full Text] [Related]

  • 10. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
    Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B.
    J Immunol; 2004 Aug 01; 173(3):2167-73. PubMed ID: 15265954
    [Abstract] [Full Text] [Related]

  • 11. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.
    Diabet Med; 1997 Aug 01; 14(8):678-85. PubMed ID: 9272595
    [Abstract] [Full Text] [Related]

  • 12. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
    Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M.
    Neuroimmunomodulation; 2004 Aug 01; 11(4):209-13. PubMed ID: 15249726
    [Abstract] [Full Text] [Related]

  • 13. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay.
    Masuda M, Powell M, Chen S, Beer C, Fichna P, Rees Smith B, Furmaniak J.
    Clin Chim Acta; 2000 Jan 20; 291(1):53-66. PubMed ID: 10612717
    [Abstract] [Full Text] [Related]

  • 14. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW, Jun HS.
    Ann N Y Acad Sci; 2001 Apr 20; 928():200-11. PubMed ID: 11795511
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I.
    Autoimmunity; 1998 Apr 20; 27(3):159-77. PubMed ID: 9609134
    [Abstract] [Full Text] [Related]

  • 16. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.
    Nielsen CH, Hegedüs L, Rieneck K, Moeller AC, Leslie RG, Bendtzen K.
    Clin Exp Immunol; 2007 Feb 20; 147(2):287-95. PubMed ID: 17223970
    [Abstract] [Full Text] [Related]

  • 17. Changes in Th1/Th2 cytokine balance in Graves' disease.
    Kocjan T, Wraber B, Repnik U, Hojker S.
    Pflugers Arch; 2000 Feb 20; 440(5 Suppl):R94-5. PubMed ID: 11005626
    [Abstract] [Full Text] [Related]

  • 18. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls.
    Ott PA, Herzog BA, Quast S, Hofstetter HH, Boehm BO, Tary-Lehmann M, Durinovic-Bello I, Berner BR, Lehmann PV.
    Clin Immunol; 2005 Apr 20; 115(1):102-14. PubMed ID: 15870028
    [Abstract] [Full Text] [Related]

  • 19. Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease.
    Kocjan T, Wraber B, Kocijancic A, Hojker S.
    J Endocrinol Invest; 2004 Apr 20; 27(4):302-7. PubMed ID: 15233546
    [Abstract] [Full Text] [Related]

  • 20. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y.
    Clin Exp Immunol; 2004 Dec 20; 138(3):417-22. PubMed ID: 15544617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.